| The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic … MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, ... Alzheimer's & dementia 7 (3), 270-279, 2011 | 7280 | 2011 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia K Rascovsky, JR Hodges, D Knopman, MF Mendez, JH Kramer, ... Brain 134 (9), 2456-2477, 2011 | 3196 | 2011 |
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nature genetics 45 (12), 1452-1458, 2013 | 2884 | 2013 |
| Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The Lancet 390 (10113), 2673-2734, 2017 | 2851 | 2017 |
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ... Nature genetics 41 (10), 1088-1093, 2009 | 2681 | 2009 |
| Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... N Engl J Med 367, 795-804, 2012 | 2660 | 2012 |
| Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ... The Lancet Neurology 12 (8), 822-838, 2013 | 2504 | 2013 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 2295 | 2014 |
| Revising the definition of Alzheimer's disease: a new lexicon B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ... The Lancet Neurology 9 (11), 1118-1127, 2010 | 2028 | 2010 |
| The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods CR Jack Jr, MA Bernstein, NC Fox, P Thompson, G Alexander, D Harvey, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2008 | 2018 | 2008 |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ... Nature genetics 43 (5), 429-435, 2011 | 1656 | 2011 |
| Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ... New England Journal of Medicine 370 (4), 322-333, 2014 | 1500 | 2014 |
| The clinical use of structural MRI in Alzheimer disease GB Frisoni, NC Fox, CR Jack, P Scheltens, PM Thompson Nature Reviews Neurology 6 (2), 67-77, 2010 | 1471 | 2010 |
| Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial S Gilman, M Koller, RS Black, L Jenkins, SG Griffith, NC Fox, L Eisner, ... Neurology 64 (9), 1553-1562, 2005 | 1340 | 2005 |
| Automatic classification of MR scans in Alzheimer's disease S Klöppel, CM Stonnington, C Chu, B Draganski, RI Scahill, JD Rohrer, ... Brain 131 (3), 681-689, 2008 | 1176 | 2008 |
| Fast free-form deformation using graphics processing units M Modat, GR Ridgway, ZA Taylor, M Lehmann, J Barnes, DJ Hawkes, ... Computer methods and programs in biomedicine 98 (3), 278-284, 2010 | 877 | 2010 |
| A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging RI Scahill, C Frost, R Jenkins, JL Whitwell, MN Rossor, NC Fox Archives of neurology 60 (7), 989-994, 2003 | 820 | 2003 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 810 | 2009 |
| Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI RI Scahill, JM Schott, JM Stevens, MN Rossor, NC Fox Proceedings of the National Academy of Sciences 99 (7), 4703-4707, 2002 | 769 | 2002 |
| A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease S Salloway, R Sperling, S Gilman, NC Fox, K Blennow, M Raskind, ... Neurology 73 (24), 2061-2070, 2009 | 764 | 2009 |
Jonathan SchottInstitute of Neurology, UCLVerified email at ucl.ac.uk
